BioSpace News Archive

Adamis Pharmaceuticals Corporation, a commercial-stage biopharmaceutical company, announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.

Senderra Specialty Pharmacy announced today that patients can access several HUMIRA biosimilar medications through Senderra’s pharmaceutical manufacturing partnerships.

Mersana Therapeutics, Inc. announced that on August 1, 2023, an authorized sub-committee of the Board of Directors of Mersana granted inducement awards, consisting of stock options to purchase an aggregate of 38,775 shares of its common stock and restricted stock unit awards to acquire an aggregate of 27,655 shares of its common stock, to two new employees whose employment commenced in July 2023.

Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Monday, August 14, 2023, at 8:30 a.m. ET to discuss a corporate update and financial results for the second quarter of 2023.

Faron Pharmaceuticals Ltd will report its unaudited half-year financial results for the six months ended June 30, 2023, on Tuesday, August 29, 2023.

Belite Bio, Inc today announced that it will host a live webcast on Wednesday, August 9, 2023, at 4:30 p.m. Eastern Time to discuss the Company’s financial results for the second quarter ended June 30, 2023.

INOVIO today announced that it has made equity grants to two newly hired employees under its 2022 Inducement Plan.

Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended June 30, 2023, on Wednesday, August 9, 2023, before the market opens.